A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
عنوان الدراسة
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
داعم الدراسة
NRG Oncology King Faisal Specialist Hospital & Research Center
دواء الدراسة
CISPLATIN (CISPLATYL )
رقم بروتوكول الدراسة
NRG-HN002
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
2
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.